These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9010296)

  • 21. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication.
    Cherry E; Morin N; Wainberg MA
    AIDS; 1998 Jun; 12(9):967-75. PubMed ID: 9662192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.
    Gay B; Tournier J; Chazal N; Carrière C; Boulanger P
    Virology; 1998 Aug; 247(2):160-9. PubMed ID: 9705909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of intracellular human immunodeficiency virus type-1 protease activity.
    Gatlin J; Arrigo SJ; Schmidt MG
    Virology; 1998 Apr; 244(1):87-96. PubMed ID: 9581782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporation of pseudorabies virus gD into human immunodeficiency virus type 1 Gag particles produced in baculovirus-infected cells.
    Garnier L; Ravallec M; Blanchard P; Chaabihi H; Bossy JP; Devauchelle G; Jestin A; Cerutti M
    J Virol; 1995 Jul; 69(7):4060-8. PubMed ID: 7769663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
    Stewart L; Vogt VM
    Virology; 1994 Oct; 204(1):45-59. PubMed ID: 7522375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
    Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of immature and mature genomic RNA dimers in wild-type and protease-inactive HIV-1: differential roles of the Gag polyprotein, nucleocapsid proteins NCp15, NCp9, NCp7, and the dimerization initiation site.
    Jalalirad M; Laughrea M
    Virology; 2010 Nov; 407(2):225-36. PubMed ID: 20828778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.
    Cherry E; Liang C; Rong L; Quan Y; Inouye P; Li X; Morin N; Kotler M; Wainberg MA
    J Mol Biol; 1998 Nov; 284(1):43-56. PubMed ID: 9811541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein.
    Paulus C; Hellebrand S; Tessmer U; Wolf H; Kräusslich HG; Wagner R
    J Biol Chem; 1999 Jul; 274(31):21539-43. PubMed ID: 10419458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.
    Konvalinka J; Litterst MA; Welker R; Kottler H; Rippmann F; Heuser AM; Kräusslich HG
    J Virol; 1995 Nov; 69(11):7180-6. PubMed ID: 7474139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of infectious virus particles by transient co-expression of human immunodeficiency virus type 1 gag mutants.
    Chen YL; Ts'ai PW; Yang CC; Wang CT
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2497-501. PubMed ID: 9349470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active.
    Kotler M; Arad G; Hughes SH
    J Virol; 1992 Nov; 66(11):6781-3. PubMed ID: 1404618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse transcriptase and protease activities of avian leukosis virus Gag-Pol fusion proteins expressed in insect cells.
    Stewart L; Vogt VM
    J Virol; 1993 Dec; 67(12):7582-96. PubMed ID: 7693975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.
    Mergener K; Fäcke M; Welker R; Brinkmann V; Gelderblom HR; Kräusslich HG
    Virology; 1992 Jan; 186(1):25-39. PubMed ID: 1727601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
    Bouamr F; Garnier L; Rayne F; Verna A; Rebeyrotte N; Cerutti M; Mamoun RZ
    Virology; 2000 Dec; 278(2):597-609. PubMed ID: 11118382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.